Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 50466510

Waters Corp Waters ACQUITY UPLC Protein BEH SEC Guard Column, 450 Å 2.5 μm, 4.6 × 30 mm

Catalog No. 50466510 Shop All Waters Chromatography Solutions Products
Encompass_Preferred

This guard column kit features an advanced, ultra-low volume device with BEH450, SEC, 2.5 μm particles, manufactured under cGMP and ISO 9001 standards. It monitors protein aggregates via SEC, improving assay resolution and sensitivity.

  • Advanced guard device (4.6 mm ID × 30 mm) with BEH450, SEC, 2.5 μm particles
  • cGMP and ISO 9001 compliant manufacturing
  • Improves assay resolution, throughput, and sensitivity
  • Rapidly monitors protein aggregates by size-exclusion chromatography (SEC)
  • BEH particle technology for proteins with molecular weights from 100,000 to 1,500,000 Daltons
  • Ensures batch-to-batch consistency via QC testing
  • Minimizes secondary interactions, allowing less aggressive mobile phases
  • Optimized for biotherapeutic analyses, separating monomers from aggregates

Catalog No. 50-466-510 Supplier Waters Corp Supplier No. 186006850
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

This guard column kit features an advanced, ultra-low volume device with BEH450, SEC, 2.5 μm particles, manufactured under cGMP and ISO 9001 standards. It monitors protein aggregates via SEC, improving assay resolution and sensitivity.

  • Advanced guard device (4.6 mm ID × 30 mm) with BEH450, SEC, 2.5 μm particles
  • cGMP and ISO 9001 compliant manufacturing
  • Improves assay resolution, throughput, and sensitivity
  • Rapidly monitors protein aggregates by size-exclusion chromatography (SEC)
  • BEH particle technology for proteins with molecular weights from 100,000 to 1,500,000 Daltons
  • Ensures batch-to-batch consistency via QC testing
  • Minimizes secondary interactions, allowing less aggressive mobile phases
  • Optimized for biotherapeutic analyses, separating monomers from aggregates

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.